It was an interventional case control study on CKD patients with and without yoga in a tertiary carehospital. About 60 CKD patientsaged >18 years were enrolled for the study and were divided into 2 groups of 30 each. Subjects in Group 1 who underwent yogatherapy. Group 2 subjects did not do yoga and they served as controls. Serumlipid profile, RFT and BP were estimated for all patients. Chi-square test, Paired and unpaired t test, mean and delta change were used for comparison. A p-value of <0.05 was considered statistically significant.
Results:
Out of 60 patients, males were predominant. There was significant reduction in Triglycerides, LDL and VLDL in the yoga group. Total cholesterol also reduced but was not statistically significant. HDL also increased but insignificant statistically.
Conclusions:
Yogatherapy can be a new added adjuvant and cost effective to the standard lipid lowering agent to reduce the lipid levels in CKD patients.